Cresco Labs Stock Price, News & Analysis (OTCMKTS:CRLBF) $1.79 +0.09 (+5.45%) (As of 12/1/2023 08:55 PM ET) Add Compare Share Share Today's Range$1.62▼$1.8250-Day Range$1.11▼$2.1352-Week Range$1.00▼$4.20Volume581,400 shsAverage Volume685,395 shsMarket Capitalization$620.15 millionP/E RatioN/ADividend YieldN/APrice Target$18.94 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Cresco Labs MarketRank™ Stock AnalysisAnalyst RatingHold2.29 Rating ScoreUpside/Downside955.4% Upside$18.94 Price TargetShort InterestHealthy0.48% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.41) to ($0.07) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.69 out of 5 stars 3.1 Analyst's Opinion Consensus RatingCresco Labs has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on 2 buy ratings, 5 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $18.94, Cresco Labs has a forecasted upside of 955.4% from its current price of $1.79.Amount of Analyst CoverageCresco Labs has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted0.48% of the outstanding shares of Cresco Labs have been sold short.Short Interest Ratio / Days to CoverCresco Labs has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cresco Labs has recently decreased by 0.24%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldCresco Labs does not currently pay a dividend.Dividend GrowthCresco Labs does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRLBF. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Cresco Labs this week, compared to 2 articles on an average week.Search Interest5 people have searched for CRLBF on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cresco Labs insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.14% of the stock of Cresco Labs is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Cresco Labs are expected to grow in the coming year, from ($0.41) to ($0.07) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cresco Labs is -1.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cresco Labs is -1.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCresco Labs has a P/B Ratio of 1.06. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Cresco Labs Stock (OTCMKTS:CRLBF)Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. Cresco Labs Inc. was incorporated in 1990 and is headquartered in Chicago, Illinois.Read More CRLBF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRLBF Stock News HeadlinesDecember 3, 2023 | americanbankingnews.comCresco Labs Inc. (OTCMKTS:CRLBF) Given Average Rating of "Hold" by BrokeragesNovember 23, 2023 | markets.businessinsider.comRobust Financial Health and Operational Efficiency: Neal Gilmer Recommends ‘Buy’ for Cresco LabsDecember 4, 2023 | Edge On The Street (Ad)Is This The Most Overlooked Gold Investment Strategy of 2024?There is little debate on the potential of gold in the next year and decade. The real issue becomes - what's the best gold investment strategy today? Some investors are opting for a unique "royalty" alternative that outshines other options like holding gold bullion or investing in volatile mining stocks.November 16, 2023 | markets.businessinsider.comCresco Labs’ Operational Turnaround and Future Challenges: Assessing Q3 2023 Performance and 2024 ProjectionsNovember 16, 2023 | marketwatch.comCresco Labs Shares Unwind Yesterday's GainsNovember 16, 2023 | realmoney.thestreet.comCresco Labs upgraded to Speculative Buy from Market Perform at CormarkNovember 15, 2023 | msn.comCresco Labs’ stock rises as revenue beats analyst estimateNovember 15, 2023 | msn.comStrong Margins And Cash Flow Drive Cresco's Q3 Performance Despite Revenue DeclineDecember 4, 2023 | Edge On The Street (Ad)Is This The Most Overlooked Gold Investment Strategy of 2024?There is little debate on the potential of gold in the next year and decade. The real issue becomes - what's the best gold investment strategy today? Some investors are opting for a unique "royalty" alternative that outshines other options like holding gold bullion or investing in volatile mining stocks.November 15, 2023 | finance.yahoo.comCresco Labs Reports Third Quarter 2023 Financial ResultsNovember 10, 2023 | marketwatch.comPoll signals more bullish cannabis sentiment as stocks end the week with gainsNovember 8, 2023 | finance.yahoo.comCresco Labs Commends Ohioans on Legalizing Adult-Use CannabisNovember 1, 2023 | finance.yahoo.comCresco Labs to Report Third Quarter 2023 Financial Results on November 15, 2023October 19, 2023 | markets.businessinsider.comCresco Labs Unlocks $32M In Non-Dilutive Capital Strengthening Overall BusinessOctober 19, 2023 | finance.yahoo.comCresco Labs Unlocks $32 Million in Non-Dilutive CapitalOctober 18, 2023 | msn.comWhy Cannabis Stocks Like Canopy Growth and Cresco Labs Plummeted TodayOctober 18, 2023 | msn.comWhere Will Cresco Labs Be in 3 Years?October 9, 2023 | msn.comCresco Labs Has Pulled Back And Could Be A BuyOctober 9, 2023 | markets.businessinsider.comCresco Labs Launches Six Flavors Of Sublingual Medical Marijuana In PennsylvaniaOctober 9, 2023 | finance.yahoo.comCresco Labs Launches Good News Brand in Pennsylvania with New Sweet TrochesOctober 5, 2023 | finance.yahoo.comCresco Labs Expands Sunnyside in Central Pennsylvania with New Store in AltoonaOctober 2, 2023 | msn.comThe Cannabist Company Makes Sense To Buy AgainSeptember 21, 2023 | finance.yahoo.comCresco Labs Expands Florida Brand Portfolio with Launch of FloraCal and Cresco Live Rosin and Flower ProductsSeptember 16, 2023 | msn.comCresco marijuana facility in Wawarsing has yet to create first 75 promised jobs, but maintains a commitment to the projectSeptember 13, 2023 | msn.comWhy Canopy Growth, Aurora Cannabis, and Cresco Labs Stocks Sank TodaySeptember 12, 2023 | markets.businessinsider.comCresco Labs Takes On Trulieve As Major Competitor In Florida Where Weed Market Is Poised To ExplodeSeptember 12, 2023 | finance.yahoo.comCresco Labs Opens 33rd Florida Sunnyside in Jacksonville, 70th Store NationwideSee More Headlines Receive CRLBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2023Today12/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Medicinals & botanicals Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CRLBF CUSIPN/A CIK1832928 Webwww.crescolabs.com Phone312-929-0993FaxN/AEmployees3,200Year FoundedN/APrice Target and Rating Average Stock Price Target$18.94 High Stock Price Target$34.00 Low Stock Price Target$2.50 Potential Upside/Downside+955.4%Consensus RatingHold Rating Score (0-4)2.29 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($1.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-212,050,000.00 Net Margins-43.40% Pretax Margin-40.47% Return on Equity-11.72% Return on Assets-4.12% Debt Debt-to-Equity Ratio1.50 Current Ratio1.16 Quick Ratio0.72 Sales & Book Value Annual Sales$842.68 million Price / Sales0.74 Cash FlowN/A Price / Cash FlowN/A Book Value$1.23 per share Price / Book1.46Miscellaneous Outstanding Shares345,620,000Free FloatN/AMarket Cap$620.15 million OptionableNot Optionable Beta2.46 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Thomas J. Manning (Age 67)Executive Chairman of the Board Comp: $800.05kMr. Charles Bachtell (Age 44)Co-Founder, CEO & Director Comp: $999.85kMr. Robert M. Sampson (Age 48)Co-Founder & Independent Director Mr. Dennis M. Olis (Age 60)Chief Financial Officer Comp: $622.85kMr. Ty Gent (Age 64)Chief Operating Officer Ms. Brenna Albert CPASenior VP and Controller of Accounting, Treasury & TaxMr. Zach Marburger (Age 38)Chief Information Officer Jake GravesManager of Investor RelationsMr. John Schetz (Age 45)General Counsel Mr. Jason Erkes (Age 52)Chief Communications Officer More ExecutivesKey CompetitorsCanopy GrowthNASDAQ:CGCCronos GroupNASDAQ:CRONbioteNASDAQ:BTMDAscend WellnessOTC:AAWHUSANA Health SciencesNYSE:USNAView All Competitors CRLBF Stock Analysis - Frequently Asked Questions Should I buy or sell Cresco Labs stock right now? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CRLBF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRLBF, but not buy additional shares or sell existing shares. View CRLBF analyst ratings or view top-rated stocks. What is Cresco Labs' stock price target for 2024? 7 Wall Street research analysts have issued 1 year target prices for Cresco Labs' stock. Their CRLBF share price targets range from $2.50 to $34.00. On average, they expect the company's stock price to reach $18.94 in the next twelve months. This suggests a possible upside of 955.4% from the stock's current price. View analysts price targets for CRLBF or view top-rated stocks among Wall Street analysts. How have CRLBF shares performed in 2023? Cresco Labs' stock was trading at $1.80 at the beginning of the year. Since then, CRLBF stock has decreased by 0.3% and is now trading at $1.7943. View the best growth stocks for 2023 here. How were Cresco Labs' earnings last quarter? Cresco Labs Inc. (OTCMKTS:CRLBF) posted its quarterly earnings data on Wednesday, November, 15th. The company reported ($0.04) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.04). The firm earned $190.56 million during the quarter, compared to the consensus estimate of $184.75 million. Cresco Labs had a negative net margin of 43.40% and a negative trailing twelve-month return on equity of 11.72%. How do I buy shares of Cresco Labs? Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:CRLBF) was last updated on 12/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cresco Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.